🇺🇸 FDA
Patent

US 7795274

5-lipoxygenase-activating protein (FLAP) inhibitors

granted A61PA61P1/00A61P11/00

Quick answer

US patent 7795274 (5-lipoxygenase-activating protein (FLAP) inhibitors) held by AMIRA PHARMACEUTICALS, INC. expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AMIRA PHARMACEUTICALS, INC.
Grant date
Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P1/00, A61P11/00, A61P11/06, A61P11/08